GO
Loading...

Beating Forecasts and There's More to Come: CEO

Thursday, 9 Aug 2012 | 3:30 AM ET

Sales of Novo Nordisk's diabetes drug Victoza soar 83 percent and there are more innovative drugs in the pipeline, Jesper Brandgaard, CFO of Novo Nordisk told CNBC.